DexCom, Inc. (DXCM) Reports Q1 Loss of 17c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $91.08 +0.31%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
DexCom, Inc. (NASDAQ: DXCM) reported Q1 EPS of ($0.17),may not compare the analyst estimate of ($0.08). Revenue for the quarter came in at $46.7 million versus the consensus estimate of $44.15 million.
For earnings history and earnings-related data on DexCom, Inc. (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
